67 related articles for article (PubMed ID: 6918338)
1. [Sensitivity testing of chemotherapeutic agents for ovarian and breast cancers--possibilities and limits of different methods and of their application (author's transl)].
Kaufmann M; Volm M; Mattern J; Kubli F
Geburtshilfe Frauenheilkd; 1982 Mar; 42(3):161-5. PubMed ID: 6918338
[TBL] [Abstract][Full Text] [Related]
2. [Drug sensitivity testing of gynecologic tumors using Volm's test and stem cell assay].
Eidtmann H; Jonat W; Maass H
Geburtshilfe Frauenheilkd; 1985 Jul; 45(7):477-81. PubMed ID: 4029587
[TBL] [Abstract][Full Text] [Related]
3. The effect of HER-2/neu overexpression on chemotherapeutic drug sensitivity in human breast and ovarian cancer cells.
Pegram MD; Finn RS; Arzoo K; Beryt M; Pietras RJ; Slamon DJ
Oncogene; 1997 Jul; 15(5):537-47. PubMed ID: 9247307
[TBL] [Abstract][Full Text] [Related]
4. Soft agar clonogenic assay for primary human renal carcinoma: in vitro chemotherapeutic drug sensitivity testing.
Lieber MM; Kovach JS
Invest Urol; 1981 Sep; 19(2):111-4. PubMed ID: 7275551
[TBL] [Abstract][Full Text] [Related]
5. Anticancer Drug Development: The Way Forward.
Connors T
Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
[TBL] [Abstract][Full Text] [Related]
6. [Pretherapeutic detection of tumour resistance to cytostatic agents].
Volm M; Mattern J
Wien Klin Wochenschr; 1982 Nov; 94(22):599-604. PubMed ID: 7164463
[TBL] [Abstract][Full Text] [Related]
7. [Value of the tumor colony assay in therapy planning in malignant ovarian tumors].
Schieder K; Kölbl H; Bieglmayer C
Geburtshilfe Frauenheilkd; 1987 Jan; 47(1):41-4. PubMed ID: 3569826
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity of drug resistance in human breast and ovarian cancers.
Kern DH
Cancer J Sci Am; 1998; 4(1):41-5. PubMed ID: 9467045
[TBL] [Abstract][Full Text] [Related]
9. [Testing of solid tumors in childhood for sensitivity against cytostatic agents using an autoradiographic in vitro method (short-term method) (author's transl)].
Willnow U
Arch Geschwulstforsch; 1979; 49(3):201-10. PubMed ID: 227341
[TBL] [Abstract][Full Text] [Related]
10. Cellular levels of aldehyde dehydrogenases (ALDH1A1 and ALDH3A1) as predictors of therapeutic responses to cyclophosphamide-based chemotherapy of breast cancer: a retrospective study. Rational individualization of oxazaphosphorine-based cancer chemotherapeutic regimens.
Sládek NE; Kollander R; Sreerama L; Kiang DT
Cancer Chemother Pharmacol; 2002 Apr; 49(4):309-21. PubMed ID: 11914911
[TBL] [Abstract][Full Text] [Related]
11. [In vitro culture of clonogenic cells from various human tumors: chemosensitivity tests].
Bénard J; Riou G
Bull Cancer; 1984; 71(4):287-91. PubMed ID: 6093913
[TBL] [Abstract][Full Text] [Related]
12. [-Chemosensitivity testing in gynecologic oncology. Experiences with an ATP bioluminescence assay-].
Kurbacher CM; Mallmann P; Kurbacher JA; Hübner H; Krebs D
Geburtshilfe Frauenheilkd; 1996 Feb; 56(2):70-8. PubMed ID: 8647362
[TBL] [Abstract][Full Text] [Related]
13. Is chemosensitivity testing for peri-operative treatment planning in gastro-intestinal cancer by the human tumour colony assay worthwhile?
Flentje D; Schlag P
Eur J Surg Oncol; 1985 Sep; 11(3):227-33. PubMed ID: 2993033
[TBL] [Abstract][Full Text] [Related]
14. Predictive value of the ATP chemosensitivity assay in epithelial ovarian cancer.
O'Meara AT; Sevin BU
Gynecol Oncol; 2001 Nov; 83(2):334-42. PubMed ID: 11606094
[TBL] [Abstract][Full Text] [Related]
15. [Human tumor clonogenic assay in human breast cancer].
Kobayashi T; Kuraishi Y; Aiba K; Inoue K
Gan To Kagaku Ryoho; 1985 Aug; 12(8):1566-72. PubMed ID: 3927846
[TBL] [Abstract][Full Text] [Related]
16. Cost-effective treatment of women with advanced ovarian cancer by cytoreductive surgery and chemotherapy directed by an in vitro assay for drug resistance.
Orr JW; Orr P; Kern DH
Cancer J Sci Am; 1999; 5(3):174-8. PubMed ID: 10367175
[TBL] [Abstract][Full Text] [Related]
17. Chemosensitivity testing of human tumors using a microplate adenosine triphosphate luminescence assay: clinical correlation for cisplatin resistance of ovarian carcinoma.
Andreotti PE; Cree IA; Kurbacher CM; Hartmann DM; Linder D; Harel G; Gleiberman I; Caruso PA; Ricks SH; Untch M
Cancer Res; 1995 Nov; 55(22):5276-82. PubMed ID: 7585588
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the human tumor cloning and subrenal capsule assays.
Bogden AE; Von Hoff DD
Cancer Res; 1984 Mar; 44(3):1087-90. PubMed ID: 6692394
[TBL] [Abstract][Full Text] [Related]
19. [Testing of sensitivity of human tumours to cytostatics in a rapid in vitro test (author's transl)].
Volm M
Dtsch Med Wochenschr; 1980 Oct; 105(43):1493-6. PubMed ID: 7428654
[TBL] [Abstract][Full Text] [Related]
20. TCA-100 tumour chemosensitivity assay: differences in sensitivity between cultured tumour cell lines and clinical studies.
Andreotti PE; Linder D; Hartmann DM; Cree IA; Pazzagli M; Bruckner HW
J Biolumin Chemilumin; 1994; 9(6):373-8. PubMed ID: 7879653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
